Skip to main content
Back to News
Edison Scientific raised 70 million dollars at a 250 million dollar valuation to scale its autonomou...
Funding
1 min read
US

Edison Scientific raised 70 million dollars at a 250 million dollar valuation to scale its autonomou...

The AMW Read

Updates the Vertical AI - Healthcare/Bio segment with a player demonstrating the transition of AI agents from information retrieval to autonomous scientific discovery (agentic workflows) in drug discovery.
NoveltySignificance
Healthcare & Bio Β· Player MapAI Agents Β· Definition

Edison Scientific raised 70 million dollars at a 250 million dollar valuation to scale its autonomous researcher, Kosmos. πŸ§ͺ The system processes 1,500 papers and 42,000 lines of code per run, turning six months of labor into a 12-hour task. With a 79 percent reproducibility rate, it has already identified novel genetic targets for heart failure. This marks a structural pivot where AI agents transition from simple information retrieval to verifiable, high-speed scientific discovery. πŸš€

#AI #Biotech #EdisonScientific #Innovation

How This Connects

Based on Healthcare & Bio Β· Player Map

  1. 1d agoMoleculeOS launches as AI operating system for biology R&D, signaling platform shift in drug discoveryMoleculeOS
  2. 1w agoAnthropic releases Claude Science Beta, a multi-agent AI workbench designed to run end-to-end resear...Anthropic
  3. 1w agoBaiyao Tech (η™Ύζ›œη§‘ζŠ€) releases AURA CellOS, first AI virtual cell based on LLM-JEPA architecture.η™Ύζ›œη§‘ζŠ€
  4. 1w agoAnthropic launches Claude Science AI workbench for life sciences researchAnthropic
  5. 6mo agoEdison Scientific raised 70 million dollars at a 250 million dollar valuation to scale its autonomou... Β· THIS ARTICLE

More news from Edison Scientific

Stay updated with the latest news and announcements from Edison Scientific.

View all Edison Scientific news

Discover AI Startups

Explore 2,000+ AI companies with VC-grade analysis, funding data, and investment insights.

Explore Dashboard